162 related articles for article (PubMed ID: 15531912)
1. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas.
Soung YH; Lee JW; Kim SY; Sung YJ; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Oncogene; 2005 Jan; 24(1):141-7. PubMed ID: 15531912
[TBL] [Abstract][Full Text] [Related]
2. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas.
Soung YH; Lee JW; Kim SY; Jang J; Park YG; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
Cancer Res; 2005 Feb; 65(3):815-21. PubMed ID: 15705878
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of caspase-14 gene in common carcinomas.
Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas.
Lee JW; Kim MR; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2006 Sep; 114(9):646-50. PubMed ID: 16948818
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of caspase 1, 4, and 5 genes in common human cancers.
Soung YH; Jeong EG; Ahn CH; Kim SS; Song SY; Yoo NJ; Lee SH
Hum Pathol; 2008 Jun; 39(6):895-900. PubMed ID: 18430458
[TBL] [Abstract][Full Text] [Related]
6. Inactivating mutations of CASPASE-7 gene in human cancers.
Soung YH; Lee JW; Kim HS; Park WS; Kim SY; Lee JH; Park JY; Cho YG; Kim CJ; Park YG; Nam SW; Jeong SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Oncogene; 2003 Sep; 22(39):8048-52. PubMed ID: 12970753
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas.
Soung YH; Lee JW; Kim SY; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
APMIS; 2006 Apr; 114(4):292-7. PubMed ID: 16689829
[TBL] [Abstract][Full Text] [Related]
8. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
[TBL] [Abstract][Full Text] [Related]
9. Inactivating mutations of proapoptotic Bad gene in human colon cancers.
Lee JW; Soung YH; Kim SY; Nam SW; Kim CJ; Cho YG; Lee JH; Kim HS; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
Carcinogenesis; 2004 Aug; 25(8):1371-6. PubMed ID: 15033904
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the BRCA2 gene in hepatocellular carcinomas.
Katagiri T; Nakamura Y; Miki Y
Cancer Res; 1996 Oct; 56(20):4575-7. PubMed ID: 8840963
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of caspase genes in prostate carcinomas.
Kim MS; Park SW; Kim YR; Lee JY; Lim HW; Song SY; Yoo NJ; Lee SH
APMIS; 2010 Apr; 118(4):308-12. PubMed ID: 20402676
[TBL] [Abstract][Full Text] [Related]
12. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
[TBL] [Abstract][Full Text] [Related]
13. Inactivating mutation of the pro-apoptotic gene BID in gastric cancer.
Lee JH; Soung YH; Lee JW; Park WS; Kim SY; Cho YG; Kim CJ; Seo SH; Kim HS; Nam SW; Yoo NJ; Lee SH; Lee JY
J Pathol; 2004 Apr; 202(4):439-45. PubMed ID: 15095271
[TBL] [Abstract][Full Text] [Related]
14. Inactivating mutations of caspase-8 gene in colorectal carcinomas.
Kim HS; Lee JW; Soung YH; Park WS; Kim SY; Lee JH; Park JY; Cho YG; Kim CJ; Jeong SW; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Gastroenterology; 2003 Sep; 125(3):708-15. PubMed ID: 12949717
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations of mitochondrial genome in hepatocellular carcinoma.
Yin PH; Wu CC; Lin JC; Chi CW; Wei YH; Lee HC
Mitochondrion; 2010 Mar; 10(2):174-82. PubMed ID: 20006738
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
[TBL] [Abstract][Full Text] [Related]
17. Expressional analysis of anti-apoptotic phospho-BAD protein and mutational analysis of pro-apoptotic BAD gene in hepatocellular carcinomas.
Yoo NJ; Lee JW; Jeong EG; Soung YH; Nam SW; Lee JY; Lee SH
Dig Liver Dis; 2006 Sep; 38(9):683-7. PubMed ID: 16807152
[TBL] [Abstract][Full Text] [Related]
18. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
Tanaka S; Toh Y; Adachi E; Matsumata T; Mori R; Sugimachi K
Cancer Res; 1993 Jun; 53(12):2884-7. PubMed ID: 8389246
[TBL] [Abstract][Full Text] [Related]
19. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
20. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
